Poseida Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for P-BCMA-ALLO1 to Treat Relapsed/Refractory Multiple Myeloma
Allogene Therapeutics(ALLO) Prnewswire·2024-09-16 20:00Allogene Therapeutics(ALLO) Prnewswire·2024-09-16 20:00